12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Auxilium, GlaxoSmithKline sales and marketing update

Auxilium disclosed in its 2Q13 earnings that it and GlaxoSmithKline mutually terminated a 2012 deal granting the pharma exclusive rights in the U.S. to co-promote Auxilium's Testim...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >